World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
73
Citations
21973
World Ranking
1269
National Ranking
652

Mark A. Behlke publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Mark A. Behlke sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 205 publications — 60th percentile

60% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Mark A. Behlke D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Mark A. Behlke sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 73 D-Index — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Mark A. Behlke is affiliated with Integrated DNA Technologies in the United States. Their research primarily spans the fields of biochemistry, genetics, molecular biology, and medicine, with significant contributions to molecular biology, immunology, oncology, genetics, and physiology. Their work is distributed across several relevant topics, including CRISPR and genetic engineering, RNA interference and gene delivery, immune cell function and interaction, advanced biosensing and bioanalysis techniques, CAR-T cell therapy research, immune response and inflammation, and erythrocyte function and pathophysiology.

Among their recent publications are notable papers that showcase a focus on genome editing technologies, immune modulation, and cell therapy development. These include:

  • CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy (2020) published in Science Advances
  • Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells (2020) published in Blood
  • AsCas12a ultra nuclease facilitates the rapid generation of therapeutic cell medicines (2021) published in Nature Communications
  • Gene replacement of α-globin with β-globin restores hemoglobin balance in β-thalassemia-derived hematopoietic stem and progenitor cells (2021) published in Nature Medicine
  • Increasing CRISPR Efficiency and Measuring Its Specificity in HSPCs Using a Clinically Relevant System (2020) published in Molecular Therapy - Methods & Clinical Development

Frequent co-authors who have collaborated with Behlke include Rolf Turk, Garrett R. Rettig, Matthew McNeill, Gavin Kurgan, and Mollie S. Schubert. This suggests active collaboration in interdisciplinary scientific teams.

Behlke's work has appeared in a range of scientific journals and venues, many of which are prominent in genetics, molecular therapy, and related biomedical fields. These include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Molecular Therapy - Methods & Clinical Development
  • Nucleic Acids Research
  • Blood
  • Nature Communications

The main scientific topics addressed in Behlke's research emphasize gene editing technologies such as CRISPR, delivery systems for RNA interference, and immune cell functionalities. Other significant themes revolve around therapeutic development using cell and gene engineering, particularly in the context of oncology and hematopoietic diseases.

Best Publications

  • Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy.

    Dong-Ho Kim;Mark A Behlke;Scott D Rose;Mi-Sook Chang

  • Identification of preexisting adaptive immunity to Cas9 proteins in humans

    Carsten T. Charlesworth;Priyanka S. Deshpande;Daniel P. Dever;Joab Camarena

  • Progress Toward In Vivo Use of siRNAs-II

    Garrett R Rettig;Mark A Behlke

  • A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells.

    Christopher A. Vakulskas;Daniel P. Dever;Garrett R. Rettig;Rolf Turk

  • Chemical Modification of siRNAs for In Vivo Use

    Mark A. Behlke

  • A structural basis for discriminating between self and nonself double-stranded RNAs in mammalian cells.

    Joao Trindade Marques;Thalie Devosse;Die Wang;Maryam Zamanian-Daryoush

  • Functional polarity is introduced by Dicer processing of short substrate RNAs

    Scott D. Rose;Dong-Ho Kim;Mohammed Amarzguioui;Jeremy D. Heidel

  • Analysis of microRNA turnover in mammalian cells following Dicer1 ablation

    Michael P. Gantier;Claire E. McCoy;Irina Rusinova;Damien Saulep

  • Chemical modification and design of anti-miRNA oligonucleotides

    K A Lennox;M A Behlke

  • Easi-CRISPR: a robust method for one-step generation of mice carrying conditional and insertion alleles using long ssDNA donors and CRISPR ribonucleoproteins

    Rolen M. Quadros;Hiromi Miura;Donald W. Harms;Hisako Akatsuka

  • Cellular localization of long non-coding RNAs affects silencing by RNAi more than by antisense oligonucleotides.

    Kim A. Lennox;Mark A. Behlke

  • Murine T-cell receptor mutants with deletions of beta-chain variable region genes

    Mark A. Behlke;Hubert S. Chou;Konrad Huppi;Dennis Y. Loh

  • Effects of sodium ions on DNA duplex oligomers: improved predictions of melting temperatures.

    Richard Owczarzy;Yong You;Bernardo G Moreira;Jeffrey A Manthey

  • Predicting Stability of DNA Duplexes in Solutions Containing Magnesium and Monovalent Cations

    Richard Owczarzy;Bernardo G. Moreira;Yong You;Mark A. Behlke

  • CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy

    Daniel Rosenblum;Anna Gutkin;Ranit Kedmi;Srinivas Ramishetti

  • Hybridization kinetics and thermodynamics of molecular beacons

    Andrew Tsourkas;Mark A. Behlke;Scott D. Rose;Gang Bao

  • Design of LNA probes that improve mismatch discrimination

    Yong You;Bernardo G. Moreira;Mark A. Behlke;Richard Owczarzy

  • Chitosan/siRNA Nanoparticle–mediated TNF-α Knockdown in Peritoneal Macrophages for Anti-inflammatory Treatment in a Murine Arthritis Model

    Kenneth A Howard;Søren R Paludan;Mark A Behlke;Flemming Besenbacher

  • miRNAs control insulin content in pancreatic β-cells via downregulation of transcriptional repressors

    Tal Melkman-Zehavi;Roni Oren;Sharon Kredo-Russo;Tirosh Shapira

  • Oligonucleotide Therapies: The Past and the Present.

    Karin E. Lundin;Olof Gissberg;C.I. Edvard Smith

Frequent Co-Authors

John J. Rossi
John J. Rossi City Of Hope National Medical Center
Paul B. McCray
Paul B. McCray University of Iowa
Gang Bao
Gang Bao Rice University
Matthew H. Porteus
Matthew H. Porteus Stanford University
James O McNamara
James O McNamara Duke University
Beverly L. Davidson
Beverly L. Davidson Children's Hospital of Philadelphia
Dennis Y. Loh
Dennis Y. Loh Washington University in St. Louis
Heng Li
Heng Li Harvard University
Samir El Andaloussi
Samir El Andaloussi Karolinska Institute
Elizabeth J. Shpall
Elizabeth J. Shpall The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Molecular Biology in the USA opens a gateway to interdisciplinary knowledge and diverse careers. Many students interested in life sciences also find value in related fields. For example, an online mathematics degree offers analytical and quantitative skills that are highly beneficial for data-intensive biological research.

Creative roles in biotech and science communication are also on the rise. Pursuing a graphic design degree online can empower graduates to visualize complex scientific concepts and contribute to educational content or scientific marketing.

If you’re seeking flexibility and a broader foundation, exploring best value online interdisciplinary studies degrees is a smart choice. These programs allow you to tailor your education with courses across biology, chemistry, technology, and more, supporting various career ambitions.

For those considering advanced study or teaching, reviewing the best online master's in history programs could provide a unique perspective. Understanding the history of science and technology can enhance your research, communication, and educational outreach within molecular biology and beyond.

Best Scientists Citing Mark A. Behlke

Trending Scientists

Recently Published Articles